NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Nan Hu
AD Scientific Index 2024
Medical and Health Sciences / Biostatistics
Genentech, Inc - South San Francisco / United States
-
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Nan Hu's MOST POPULAR ARTICLES
1-)
Evaluating the safety and efficacy of crenezumab vs placebo in adults with early Alzheimer disease: two phase 3 randomized placebo-controlled trialsS Ostrowitzki, T Bittner, KM Sink, H Mackey, C Rabe, LS Honig, ...JAMA neurology 79 (11), 1113-1121, 2022962022
2-)
Wait-list outcomes for adults with congenital heart disease listed for heart transplantation in the USLI Alshawabkeh, N Hu, KD Carter, AR Opotowsky, KA Light-McGroary, ...Journal of the American College of Cardiology 68 (9), 908-917, 2016942016
3-)
Baseline demographic, clinical, and cognitive characteristics of the Alzheimer\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s Prevention Initiative (API) Autosomal‐Dominant Alzheimer\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s Disease Colombia TrialS Rios‐Romenets, F Lopera, KM Sink, N Hu, Q Lian, H Guthrie, J Smith, ...Alzheimer\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s & Dementia 16 (7), 1023-1030, 2020152020
4-)
Sex differences in cognitive resilience in preclinical autosomal‐dominant Alzheimer\'s disease carriers and non‐carriers: baseline findings from the API ADAD Colombia TrialC Vila‐Castelar, PN Tariot, KM Sink, D Clayton, JB Langbaum, ...Alzheimer\'s & Dementia 18 (11), 2272-2282, 2022122022
5-)
Safety, tolerability, and pharmacokinetics of high‐volume subcutaneous crenezumab, with and without recombinant human hyaluronidase in healthy volunteersMJ Dolton, A Chesterman, A Moein, KM Sink, A Waitz, K Blondeau, ...Clinical Pharmacology & Therapeutics 110 (5), 1337-1348, 2021122021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept